Stock data
Sonoma Pharmaceuticals, Inc. (SNOA)
Sonoma Pharmaceuticals, Inc. (SNOA) reported revenue of US$19.53M and net income of -US$3.17M for fiscal 2026. The figures below come from the company's SEC filings.
Annual results
Data as of 2026-03-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | US$19.53M | US$7.42M | -US$2.46M | -US$3.17M | — |
| 2025 | US$14.29M | US$5.46M | -US$3.71M | -US$3.46M | — |
| 2024 | US$12.73M | US$4.75M | -US$4.70M | -US$4.83M | — |
| 2023 | US$13.27M | US$4.48M | -US$4.57M | -US$5.15M | — |
| 2022 | US$12.63M | US$3.99M | -US$5.89M | -US$5.09M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$6.41M | -US$0.33M | — |
| 2026-03-31 | US$5.56M | -US$0.58M | — |
| 2025-12-31 | US$4.35M | -US$0.82M | — |
| 2025-09-30 | US$5.60M | -US$0.53M | — |
| 2025-06-30 | US$4.01M | -US$1.24M | — |
| 2025-03-31 | US$3.75M | -US$0.78M | — |
| 2024-12-31 | US$3.56M | -US$0.93M | — |
| 2024-09-30 | US$3.58M | -US$0.61M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.